Medicine: Gesundheit!

It was a week of tantalizing news for 6,000,000 U.S. allergy victims—but most of them will probably go right on sneezing through this summer at least.

First, the eminently cautious and reliable Bulletin of the New York Academy of Medicine detailed the powers of a new drug named Anthallan. "Relief of a high percentage of cases" of hay fever was claimed for it.

At Manhattan's Columbia University Medical Center, Dr. Alexander D. Ghiselin had given 44 victims of seasonal and non-seasonal allergic "wet noses" (but not skin rashes), a three-week course of Anthallan capsules. Forty of the patients were relieved of 25% to...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!